Dr Robin Brown

Robin was appointed Chairman of the Medicines Discovery Catapult in July 2018. Most recently he was the Chief Executive Officer of KWS BioTest, a specialist immunology-based contract research organisation. In January 2018 KWS was acquired by Charles River Laboratories. Immediately before joining KWS, Robin spent eight years as a venture partner at Advent Healthcare Ventures […]